Clinical updates from the John A. Moran Eye Center’s Uveitis Division, including a new CMV screening protocol, managing patient care amid the COVID-19 pandemic, ongoing clinical trials, and selected research...
In resource-poor countries such as Myanmar, which has the second-highest number of people living with HIV in Southeast Asia, the rates of cytomegalovirus (CMV) retinitis and associated vision-threatening complications remain...
An oxysterol that accumulates in the eye with age can transform choroidal endothelial cells; interfering with the process might help patients with treatment-resistant age-related macular degeneration.
One of ophthalmology’s most prestigious research societies and other prominent organizations are tapping John A. Moran Eye Center physician-scientist Mary Elizabeth Hartnett, MD, for leadership roles in 2021 as her...
The John A. Moran Eye Center’s Global Outreach Division has expanded its donor-funded local care for uninsured and under-insured Utahns to patients with diabetes and other sight-threatening retinal conditions.
Paul S. Bernstein, MD, PhD, is investigating how lipids known as VLC-PUFAs could be used to prevent eye disease thanks to a new way to synthesize them for research.
